Researchers from The University of Western Australia and Olivia Newton-John Cancer Research Institute have found a new way to improve treatment of tumors that previously did not respond to immunotherapies.
Immunotherapy is a treatment that uses certain parts of a person’s immune system to fight diseases such as cancer. It can be done in a number of ways and involves stimulating, or boosting, the natural defenses of the immune system so that it works harder or smarter to find and attack cancer cells.
Associate Professor Fiona Pixley and Jay Steer, from UWA’s School of Biomedical Sciences, were co-authors of “Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy,” published in Science Advances.
They discovered that isolating a particular molecule found in certain immune cells that hadn’t traditionally responded well to immunotherapy could turn things around, which may ultimately lead to better responses to immunotherapies for patients with a range of cancers.
“Cancer immunotherapy has revolutionized the treatment of several cancers, such as melanoma, in the past decade but some cancers do not respond to these new therapies,” Associate Professor Pixley, Head of Pharmacology and Toxicology at UWA, said.
“Non-responding tumors are typically ‘immunologically cold’ as they contain few of the immune cells called T cells that are targeted by these immunotherapies.”
The non-responding tumors contain different immune cells, known as macrophages and dendritic cells, which are immunosuppressive and stop immunotherapy from working.
Researchers found that inhibiting a molecule called Hck, only found in macrophages and dendritic cells, changed their behavior and enabled a powerful immune response to immunotherapies.
“By combining inhibition of Hck with immunotherapy, the growth of cancers poorly responsive to immunotherapy alone was significantly reduced,” Associate Professor Pixley said.
The study found stimulating immune cell activation, while inhibiting the immunosuppressive micro-environment, enhanced T-cell infiltration, resulting in reduced tumor growth.
more recommended stories
New health research suggests novel combination therapy for triple-negative breast cancer
Research led by Suresh Alahari, Ph.D.,.
Pulse oximeter less accurate in non-white patients, study finds
It’s a device most patients will.
Researchers make a significant breakthrough in the treatment of stroke
In the largest clinical stroke trial.
Study finds women have more brain changes after menopause
Women who have gone through menopause.
Smoking promotes development of severe pulmonary hypertension
About 1% of the world’s adult.
Researchers find two FDA-approved drugs that curb symptoms of Alzheimer’s disease
Two commonly used psychiatric drugs show.
Cancer drug shows potential as treatment for muscular dystrophy
Researchers at the University of British.
Research team works to develop a non-invasive, low-cost test for head and neck cancer
Can screening for head and neck.
Innovative lung-imaging technique shows cause of long COVID symptoms
Many who experience what is now.
Focus on beta cells instead of immune system could be key to preventing type 1 diabetes
Research into the causes of type.